LIV-GAMMA SN Inj.

BIOLOGICAL2 trials

Sponsors

SK Plasma Co., Ltd.

Conditions

Immune ThrombocytopeniaLiver Transplantation

Phase 2

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantation

TerminatedNCT05666453

SK Plasma Co., Ltd.Liver Transplantation

Start: 2022-04-25End: 2024-07-01Updated: 2024-08-30

Phase 3

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

CompletedNCT03164915

SK Plasma Co., Ltd.Immune Thrombocytopenia

Start: 2016-10-24End: 2018-09-28Updated: 2021-03-30